BPCE
BBH icon

Bank Pictet & Cie (Europe)’s VanEck Biotech ETF BBH Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,430
Closed -$676K – 132
2014
Q1 		$676K Hold
7,430
– – 0.24% 62
2013
Q4 		$658K Buy
+7,430
New +$621K 0.26% 57

Other funds holding BBH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ECML
Eagle Capital Management (Louisiana) Mandeville, Louisiana $293M AUM 33.65% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s BBH Position: Q2 2014 in Review

Bank Pictet & Cie (Europe) sold out of VanEck Biotech ETF (BBH) in Q2 2014, closing a stake of 7,430 shares — an estimated $676K sold.

Bank Pictet & Cie (Europe) first reported a position in BBH in Q4 2013 and held it in 2 quarters. The position peaked at $676K in Q1 2014. 59 funds tracked by Wall St. Rank hold BBH as of Q2 2014.

  • Bank Pictet & Cie (Europe) reported no remaining VanEck Biotech ETF position as of Q2 2014 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 7,430 VanEck Biotech ETF shares in Q2 2014, an estimated $676K.
  • Bank Pictet & Cie (Europe) first reported a position in VanEck Biotech ETF in Q4 2013 and held it in 2 quarters.
  • Bank Pictet & Cie (Europe)'s VanEck Biotech ETF position peaked at $676K in Q1 2014.
  • 59 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2014.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2014, filed 6 Aug 2014.